EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Enhancing the Anticancer Efficacy of Decitabine via β-Hydroxybutyrate in Colorectal and Prostate Cancers Cell Lines

Sarah Khudhair Obayes, Fadhil Abduljabbar Rizij, Rana Ayad Ghaleb, Bassim Irahiem Mohammad, Najah Rayish Hadi

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 15.11.2026 · 11 (2) · 333-337

DOI: 10.54133/ajms.v11i2.3363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), online erschienen am 15.11.2026. Verfasst von Sarah Khudhair Obayes und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epigenetic targeting therapy, including histone deacetylase (HDAC) inhibitors and DNA-methyltransferase 1 (DNMT1) inhibitors, is a promising and attractive tool to treat advanced cancers, overcome drug resistance, and minimize adverse effects of traditional therapies.

Objective

To investigate whether β-hydroxybutyrate enhanced the effectiveness of decitabine against colon cancer and enhanced the anti-cancer effect of decitabine against colon and prostate cancer cell lines.

Methods

LS174T cells (colorectal cancer) and PC3 cells (prostate cancer) were seeded in a 96-well cell culture plate. Decitabine was used in six [100, 50, 25, 12.5, 6.25, & 3.125μg/ml] concentrations alone and combined with β-hydroxybutyrate, enhancing the effectiveness of decitabine against colon (2000μg/ml). After 48 hours of incubation, LS174T cells and PC3 cell viability were determined by MTT assay. DNMT1-enzyme level was measured using the DNMT1-ELISA kit.

Results

For the LS174T cell line and PC3 cell line, the combination of decitabine plus β-hydroxybutyrate enhanced the effectiveness of decitabine against colon and showed a significant (p

Zitieren

APA

Obayes, S. K., Rizij, F. A., Ghaleb, R. A., Mohammad, B. I., & Hadi, N. R. (2026). Enhancing the Anticancer Efficacy of Decitabine via β-Hydroxybutyrate in Colorectal and Prostate Cancers Cell Lines. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 11(2), 333-337. https://doi.org/10.54133/ajms.v11i2.3363

Vancouver

Obayes SK, Rizij FA, Ghaleb RA, Mohammad BI, Hadi NR. Enhancing the Anticancer Efficacy of Decitabine via β-Hydroxybutyrate in Colorectal and Prostate Cancers Cell Lines. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2026;11(2):333-337. doi:10.54133/ajms.v11i2.3363

BibTeX
@article{Obayes2026,
  author = {Obayes, Sarah Khudhair and Rizij, Fadhil Abduljabbar and Ghaleb, Rana Ayad and Mohammad, Bassim Irahiem and Hadi, Najah Rayish},
  title = {Enhancing the Anticancer Efficacy of Decitabine via β-Hydroxybutyrate in Colorectal and Prostate Cancers Cell Lines},
  journal = {Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {333--337},
  doi = {10.54133/ajms.v11i2.3363}
}
Kostenlos starten →